59
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Bimatoprost/timolol fixed combination versus latanoprost in treatment-naïve glaucoma patients at high risk of progression: a pilot study

, , , , &
Pages 725-732 | Published online: 10 Apr 2014

References

  • European Glaucoma SocietyTerminology and Guidelines for Glaucoma3rd edSavona, ItalyEditrice Dogma2008
  • LeskeMCHeijlAHymanLPredictors of long-term progression in the early manifest glaucoma trialOphthalmology20071141965197217628686
  • van der ValkRWebersCALumleyTA network meta-analysis combined direct and indirect comparisons between glaucoma drugs to rank effectiveness in lowering intraocular pressureJ Clin Epidemiol2009621279128319716679
  • AptelFCucheratMDenisPEfficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trialsJ Glaucoma20081766767319092464
  • AptelFCucheratMDenisPEfficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trialsEur J Ophthalmol20122251822167538
  • AllerganSafety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated Available from: http://clinicaltrials.gov/show/NCT01243567. NLM identifier: NCT01243567Accessed 3 February, 2014
  • [No authors listed]Good Clinical Practice Guideline 1997 Available from: http://ec.europa.eu/health/files/eudralex/vol-10/3cc1aen_en.pdfAccessed 7 February 2014
  • KonstasAGLakeSEconomouAI24-Hour control with a latanoprost-timolol fixed combination vs timolol aloneArch Ophthalmol20061241553155717102001
  • KonstasAGHolloGMikropoulosDTwenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucomaBr J Ophthalmol20109420921319825835
  • KonstasAGHolloGMikropoulosDG24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucomaBr J Ophthalmol20139785786123686322
  • HommerAA double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertensionEur J Ophthalmol200717536217294383
  • KonstasAGKozobolisVPTersisIThe efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucomaEye200317414612579169
  • QuarantaLMigliorSFlorianiIEffects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucomaInvest Ophthalmol Vis Sci2008494226423118502991
  • OzkurtYBSengorTEvcimanTAdministration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHgClin Ophthalmol2009333733919668587
  • CrichtonACHarasymowyczPHutnikCMEffectiveness of dorzolamide-timolol (COSOPT) in patients who were treatment naive for open-angle glaucoma or ocular hypertension: the COSOPT first-line studyJ Ocul Pharmacol Ther20102650351120874498
  • HendererJDWilsonRPMosterMRTimolol/dorzolamide combination therapy as initial treatment for intraocular pressure over 30 mm HgJ Glaucoma20051426727015990605
  • PajicBPajic-EggspuehlerBHafligerIOComparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucomaCurr Med Res Opin2010262213221920673200
  • BrandtJDCantorLBKatzLJBimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertensionJ Glaucoma20081721121618414107